A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner. / Kopietz, Franziska; Alshuweishi, Yazeed; Bijland, Silvia; Alghamdi, Fatmah; Degerman, Eva; Sakamoto, Kei; Salt, Ian P; Göransson, Olga.

I: The Biochemical journal, Vol. 478, Nr. 3, 25.01.2021, s. 633-646.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

Kopietz, Franziska ; Alshuweishi, Yazeed ; Bijland, Silvia ; Alghamdi, Fatmah ; Degerman, Eva ; Sakamoto, Kei ; Salt, Ian P ; Göransson, Olga. / A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner. I: The Biochemical journal. 2021 ; Vol. 478, Nr. 3. s. 633-646.

RIS

TY - JOUR

T1 - A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner

AU - Kopietz, Franziska

AU - Alshuweishi, Yazeed

AU - Bijland, Silvia

AU - Alghamdi, Fatmah

AU - Degerman, Eva

AU - Sakamoto, Kei

AU - Salt, Ian P

AU - Göransson, Olga

N1 - Copyright 2021 The Author(s).

PY - 2021/1/25

Y1 - 2021/1/25

N2 - Activation of AMP-activated protein kinase (AMPK) is considered a valid strategy for the treatment of type 2 diabetes. However, despite the importance of adipose tissue for whole-body energy homeostasis, the effect of AMPK activation in adipocytes has only been studied to a limited extent and mainly with the AMP-mimetic 5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside (AICAR), which has limited specificity. The aim of this study was to evaluate the effect of the allosteric AMPK activators A‑769662 and 991 on glucose uptake in adipocytes. For this purpose, primary rat or human adipocytes, and cultured 3T3-L1 adipocytes, were treated with either of the allosteric activators, or AICAR, and basal and insulin-stimulated glucose uptake was assessed. Additionally, the effect of AMPK activators on insulin-stimulated phosphorylation of Akt and Akt substrate of 160 kDa was assessed. Furthermore, primary adipocytes from ADaM site binding drug-resistant AMPKb1 S108A knock-in mice were employed to investigate specificity of the drugs for the observed effects. Our results show that insulin-stimulated adipocyte glucose uptake was significantly reduced by A‑769662 but not 991, yet neither activator had any clear effects on basal or insulin-stimulated Akt/AS160 signaling. The use of AMPKb1 S108A mutant-expressing adipocytes revealed that the observed inhibition of glucose uptake by A‑769662 is most likely AMPK-independent, a finding which is supported by the rapid inhibitory effect A-769662 exerts on glucose uptake in 3T3-L1 adipocytes. These data suggest that AMPK activation per se does not inhibit glucose uptake in adipocytes and that the effects of AICAR and A-769662 are AMPK-independent.

AB - Activation of AMP-activated protein kinase (AMPK) is considered a valid strategy for the treatment of type 2 diabetes. However, despite the importance of adipose tissue for whole-body energy homeostasis, the effect of AMPK activation in adipocytes has only been studied to a limited extent and mainly with the AMP-mimetic 5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside (AICAR), which has limited specificity. The aim of this study was to evaluate the effect of the allosteric AMPK activators A‑769662 and 991 on glucose uptake in adipocytes. For this purpose, primary rat or human adipocytes, and cultured 3T3-L1 adipocytes, were treated with either of the allosteric activators, or AICAR, and basal and insulin-stimulated glucose uptake was assessed. Additionally, the effect of AMPK activators on insulin-stimulated phosphorylation of Akt and Akt substrate of 160 kDa was assessed. Furthermore, primary adipocytes from ADaM site binding drug-resistant AMPKb1 S108A knock-in mice were employed to investigate specificity of the drugs for the observed effects. Our results show that insulin-stimulated adipocyte glucose uptake was significantly reduced by A‑769662 but not 991, yet neither activator had any clear effects on basal or insulin-stimulated Akt/AS160 signaling. The use of AMPKb1 S108A mutant-expressing adipocytes revealed that the observed inhibition of glucose uptake by A‑769662 is most likely AMPK-independent, a finding which is supported by the rapid inhibitory effect A-769662 exerts on glucose uptake in 3T3-L1 adipocytes. These data suggest that AMPK activation per se does not inhibit glucose uptake in adipocytes and that the effects of AICAR and A-769662 are AMPK-independent.

U2 - 10.1042/BCJ20200659

DO - 10.1042/BCJ20200659

M3 - Article

C2 - 33493298

VL - 478

SP - 633

EP - 646

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -